In vitro, overexpression or knockdown models of BID/KANK2/SMIM3 can be constructed using primary NPCs from IDD patients and control groups to detect changes in NPC senescence, proliferation, apoptosis, and ECM metabolism. The gene discussed is KANK2; the disease is intervertebral disk degenerative disorder.